Mesenchymal stromal cell therapies for neurodegenerative diseases

NP Staff, DT Jones, W Singer - Mayo Clinic Proceedings, 2019 - Elsevier
Mesenchymal stromal cells are multipotent cells that are being used to treat a variety of
medical conditions. Over the past decade, there has been considerable excitement about …

Conditioned media derived from mesenchymal stem cell cultures: The next generation for regenerative medicine

TNA Gunawardena, MT Rahman… - Journal of tissue …, 2019 - Wiley Online Library
Recent studies suggest that the main driving force behind the therapeutic activity observed
in mesenchymal stem cells (MSCs) are the paracrine factors secreted by these cells. These …

Regulation of BDNF-TrkB signaling and potential therapeutic strategies for Parkinson's disease

W Jin - Journal of clinical medicine, 2020 - mdpi.com
Brain-derived neurotrophic factor (BDNF) and its receptor tropomyosin-related kinase
receptor type B (TrkB) are widely distributed in multiple regions of the human brain …

Mesenchymal stromal cells (MSCs) for neurodegenerative disease: a promising frontier

A Shariati, R Nemati, Y Sadeghipour… - European journal of cell …, 2020 - Elsevier
Neurodegenerative disorders are a variety of diseases including Alzheimer's (AD),
Parkinson's (PD), and Huntington's diseases (HD), multiple sclerosis (MS) and amyotrophic …

The secretome of mesenchymal stem cells: potential implications for neuroregeneration

G Paul, SV Anisimov - Biochimie, 2013 - Elsevier
Mesenchymal stem cells have shown regenerative properties in many tissues. This feature
had originally been ascribed to their multipotency and thus their ability to differentiate into …

Umbilical cord stem cells: Background, processing and applications

SM Alatyyat, HM Alasmari, OA Aleid… - Tissue and Cell, 2020 - Elsevier
Stem cells have currently gained attention in the field of medicine not only due to their ability
to repair dysfunctional or damaged cells, but also they could be used as drug delivery …

[HTML][HTML] Current developments in cell replacement therapy for Parkinson's disease

X Guo, L Tang, X Tang - Neuroscience, 2021 - Elsevier
Parkinson's disease (PD) is characterized by tremor, rigidity, and bradykinesia. PD is caused
mainly by depletion of the nigrostriatal pathway. Conventional medications such as …

Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease

D Chen, W Fu, W Zhuang, C Lv, F Li… - Journal of …, 2017 - Wiley Online Library
Stem cell transplantation is a promising tool for the treatment of neurodegenerative
disorders, including Parkinson's disease (PD); however, the therapeutic routes and …

Clinical potential and current progress of mesenchymal stem cells for Parkinson's disease: a systematic review

Y Chen, J Shen, K Ke, X Gu - Neurological Sciences, 2020 - Springer
Parkinson's disease (PD) is the second most prevalent neurodegenerative disease
characterized by severe dyskinesia due to a progressive loss of dopaminergic neurons …

Human umbilical cord blood cell transplantation in neuroregenerative strategies

LR Galieva, YO Mukhamedshina… - Frontiers in …, 2017 - frontiersin.org
At present there is no effective treatment of pathologies associated with the death of neurons
and glial cells which take place as a result of physical trauma or ischemic lesions of the …